TCL Archive Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial July 25, 2014
TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012
TCL Archive Swedish Study Finds Long Term Hormonal Therapy May Increase Breast Cancer Risk August 4, 1989